⌘K

Login Start Free

Home/Filings/4/0001437749-17-016028

4//SEC Filing

Hall Justin 4

Accession 0001437749-17-016028

CIK 0001389545other

View on SEC.gov Company Profile

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 7:53 PM ET

Size

4.7 KB

Accession

0001437749-17-016028

Insider Transaction Report

Form 4

Period: 2017-09-14

NovaBay Pharmaceuticals, Inc.NBY

General Counsel

Transactions

Exercise of In-Money
stock option
2017-09-14−20,000→ 278,160 total
Exercise: $2.78From: 2017-01-31Exp: 2026-06-06→ common stock (20,000 underlying)

Documents

1 file

4
rdgdoc.xmlPrimary
HALL

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1

filerCIK 0001663021

Filing Metadata

Form type: 4
Filed: Sep 17, 8:00 PM ET
Accepted: Sep 18, 7:53 PM ET
Size: 4.7 KB

View on SEC.gov